Mayne Pharma Group Limited (ASX:MYX)
Australia · Delayed Price · Currency is AUD 3.270
+0.010 (0.31%)
Aug 12, 2026, 4:11 PM AEST
Mayne Pharma Group Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 67.35 | 59.84 | 110.07 | 92.62 | 96.67 | 97.98 |
Short-Term Investments | 0.1 | 40.56 | 39.21 | 127.53 | - | - |
Trading Asset Securities | - | - | - | - | 1.33 | - |
Cash & Short-Term Investments | 67.45 | 100.4 | 149.28 | 220.14 | 98.01 | 97.98 |
Cash Growth | -32.82% | -32.74% | -32.19% | 124.62% | 0.03% | -28.89% |
Accounts Receivable | 173.94 | 164.62 | 176.47 | 177.4 | 259.72 | 175.83 |
Other Receivables | 18.65 | 17.28 | 31.21 | 32.12 | 23.3 | 17.51 |
Receivables | 192.59 | 181.9 | 207.68 | 209.52 | 283.02 | 193.34 |
Inventory | 47.5 | 50.56 | 74.63 | 82.7 | 108.91 | 102.51 |
Prepaid Expenses | 29.25 | 16.37 | 19.2 | 13.1 | 11.57 | 8.85 |
Restricted Cash | - | 2.37 | 2.32 | 9.1 | 0.41 | 0.37 |
Other Current Assets | 4.34 | 1.19 | 7.49 | 19.08 | 9.71 | 13.48 |
Total Current Assets | 341.13 | 352.79 | 460.59 | 553.63 | 511.62 | 416.53 |
Property, Plant & Equipment | 57.11 | 58.87 | 53.33 | 51.48 | 225.86 | 221.6 |
Goodwill | - | - | - | - | 22.13 | 59.54 |
Other Intangible Assets | 499.83 | 542.11 | 567.86 | 615.23 | 396.32 | 1,068 |
Long-Term Deferred Tax Assets | 24.13 | 41.76 | 45.34 | 22.66 | 118.49 | 172.21 |
Long-Term Deferred Charges | 3.29 | 3.67 | 0.72 | 2.04 | 9.07 | -491.28 |
Other Long-Term Assets | 15.07 | 15.41 | 15.34 | 2.32 | 4.45 | 16.7 |
Total Assets | 940.55 | 1,015 | 1,143 | 1,247 | 1,288 | 1,463 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 23.31 | 30.25 | 20.87 | 32.03 | 63.57 | 42.36 |
Accrued Expenses | 163.96 | 140.41 | 179.85 | 195.87 | 113.19 | 63.78 |
Short-Term Debt | - | - | - | 10.81 | 405.37 | 51.16 |
Current Portion of Long-Term Debt | 37.05 | 35.15 | 31.64 | - | - | 1.08 |
Current Portion of Leases | 3.26 | 3.46 | 3.82 | 3.62 | 2.63 | 2.89 |
Current Income Taxes Payable | - | - | - | - | 1.22 | - |
Other Current Liabilities | 29.81 | 51.73 | 109.39 | 68.64 | 43.33 | 61.26 |
Total Current Liabilities | 257.38 | 261.01 | 345.58 | 310.96 | 629.31 | 222.53 |
Long-Term Debt | - | - | - | 28.48 | - | 285.8 |
Long-Term Leases | 2.15 | 2.66 | 3.36 | 4.6 | 5.67 | 6.97 |
Pension & Post-Retirement Benefits | 0.48 | 0.46 | 0.33 | 0.3 | 0.28 | 0.65 |
Long-Term Deferred Tax Liabilities | 6.15 | 8.8 | 7.35 | 7.8 | 6.03 | 13.46 |
Other Long-Term Liabilities | 321.68 | 371.4 | 332.37 | 260.86 | 108.4 | 162.19 |
Total Liabilities | 587.84 | 644.32 | 688.99 | 612.99 | 749.7 | 691.61 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 1,230 | 1,226 | 1,224 | 1,234 | 1,239 | 1,239 |
Retained Earnings | -1,056 | -1,041 | -944 | -769.77 | -840.35 | -559.06 |
Comprehensive Income & Other | 178.86 | 185.29 | 173.97 | 170.44 | 147.7 | 88.88 |
Total Common Equity | 352.71 | 370.28 | 454.19 | 634.36 | 545.88 | 768.36 |
Minority Interest | - | - | - | - | -7.65 | 3.22 |
Shareholders' Equity | 352.71 | 370.28 | 454.19 | 634.36 | 538.23 | 771.58 |
Total Liabilities & Equity | 940.55 | 1,015 | 1,143 | 1,247 | 1,288 | 1,463 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 42.47 | 41.27 | 38.82 | 47.51 | 413.67 | 347.9 |
Net Cash (Debt) | 24.98 | 59.13 | 110.46 | 172.64 | -315.66 | -249.92 |
Net Cash Growth | -57.75% | -46.47% | -36.02% | - | - | - |
Net Cash Per Share | 0.31 | 0.75 | 1.39 | 2.10 | -3.84 | -3.18 |
Filing Date Shares Outstanding | 81.25 | 81.25 | 81.25 | 83.42 | 88.24 | 88.24 |
Total Common Shares Outstanding | 81.25 | 81.25 | 81.25 | 83.42 | 88.24 | 88.24 |
Working Capital | 83.74 | 91.78 | 115.01 | 242.67 | -117.69 | 194 |
Book Value Per Share | 4.34 | 4.56 | 5.59 | 7.60 | 6.19 | 8.71 |
Tangible Book Value | -147.12 | -171.82 | -113.67 | 19.14 | 127.44 | -359.08 |
Tangible Book Value Per Share | -1.81 | -2.11 | -1.40 | 0.23 | 1.44 | -4.07 |
Land | 2.98 | 2.98 | 2.98 | 2.98 | 8.1 | 9.17 |
Buildings | 19.92 | 19.92 | 19.92 | 19.92 | 128.95 | 112.53 |
Machinery | 67.72 | 63.69 | 60.62 | 65.59 | 184.83 | 166.88 |
Construction In Progress | 11.15 | 14.04 | 6.63 | -0.01 | 11.18 | 15.24 |